Search

Author/Creator Carbery, Isabel

2. Impact on direct and indirect costs of switching patients with inflammatory bowel disease from intravenous to subcutaneous infliximab (CT-P13). Issue 1 (22nd February 2023)

Authors:
Carbery, Isabel; Burdge, Gemma; Clark, Tanya; Broglio, Giacomo; Greer, Dan; Alakkari, Alaa; Selinger, Christian Philipp
Journal:
BMJ open gastroenterology
Issue:
Volume 10:Issue 1(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Understanding anti‐TNF treatment failure: does serum triiodothyronine‐to‐thyroxine (T3/T4) ratio predict therapeutic outcome to anti‐TNF therapies in biologic‐naïve patients with active luminal Crohn's disease?. Issue 5 (29th June 2022)

Authors:
Lin, Simeng; Chanchlani, Neil; Carbery, Isabel; Janjua, Malik; Nice, Rachel; McDonald, Timothy J.; Bewshea, Claire; Kennedy, Nicholas A.; Ahmad, Tariq; Selinger, Christian P.; Goodhand, James R.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 56:Issue 5(2022)
Page Start:
783
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗